MedTrace Logo

Discomfort During Intravenous Cannulation in an Emergency Department: Impact of Communication

NCT03502655 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 251

Last updated 2020-07-07

No results posted yet for this study

Summary

The main goal of this study is to investigate whether the communication between patients and healthcare providers has an impact on pain and anxiety induced by the insertion of a peripheral venous catheter in an emergency department. Another goal is to determine if the effect is mediated by the content of the message in itself or if it is mediated by non-verbal cues . Therefore, the message will be delivered by either an audio recording in the first phase of the study, and by the healthcare providers themselves in the second phase of the study. A secondary goal is to assess whether there are discrepancies between the patients' pain and anxiety reports and the healthcare providers' evaluation of the patient's pain and anxiety.

Conditions

  • Pain, Acute
  • Catheterization, Peripheral

Interventions

OTHER

Experimental: Intervention message (first phase)

Effect of positive communication on pain during intravenous cannulation in an emergency department delivered by a recorded message

OTHER

Placebo Comparator: Control message (first phase)

Effect of usual communication on pain during intravenous cannulation in an emergency department delivered by a recorded message

OTHER

Experimental: Intervention message (second phase)

Effect of positive communication on pain during intravenous cannulation in an emergency department delivered by a care provider

OTHER

Placebo Comparator: Control message (second phase)

Effect of usual communication on pain during intravenous cannulation in an emergency department delivered by a care provider

Sponsors & Collaborators

  • University of Lausanne Hospitals

    collaborator OTHER

  • Olivier Hugli

    lead OTHER

Principal Investigators

  • Olivier Hugli, PD-MER, MPH · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-13
Primary Completion
2018-12-15
Completion
2019-12-15

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03502655 on ClinicalTrials.gov